Recent ONCO News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/02/2026 02:32:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/29/2025 05:15:21 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/23/2025 09:05:39 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/22/2025 09:40:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 10:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 02:28:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:26:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/10/2025 09:08:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/10/2025 06:26:52 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/04/2025 09:40:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2025 04:17:30 PM
- Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms • PR Newswire (Canada) • 10/07/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 12:16:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2025 12:45:57 PM
- Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. • GlobeNewswire Inc. • 09/26/2025 12:30:00 PM
- Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement • GlobeNewswire Inc. • 09/26/2025 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2025 12:37:50 PM
- Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM • GlobeNewswire Inc. • 09/22/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2025 08:05:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2025 08:05:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2025 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2025 08:05:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2025 08:05:17 PM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
ConnectM Subsidiary Signs Definitive Agreement with Alpex Solar to Execute Solar Deployments Worth an Initial ~$16.5M • CNTM • Feb 4, 2026 9:05 AM
The Hidden Revenue Drain in Hospitality-and How AI Robotics Is Finally Closing the Gap • NGTF • Feb 4, 2026 9:00 AM
